Saudi Arabia Diabetes Market Overview:
The Saudi Arabia diabetes market was worth US$ XX Billion in 2021, expanding at a CAGR of X% during 2016-2021. Looking forward, the market is projected to grow at a CAGR of around X% during 2022-2027, reaching a value of US$ XX Billion by 2027. Beginning with a regional overview, the report explores the dynamics that have a strong influence on the Saudi Arabia diabetes market and can also impact its future growth. Taking 2021 as the base year, the report covers historical market scenario from 2016-2021 and provides forecasts till 2027. This includes the study of value and volume trends and pricing history. Growth inducing factors, market restraints and recent developments have also been analysed in the report in order to provide a deeper knowledge about the industry.
The report analyses the competitive structure of the Saudi Arabia diabetes market industry and provides the profiles of major players operating in the market. The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the Saudi Arabia diabetes market industry along the parameters of the Porter’s Five Forces model. This model examines the degree of competition in the Saudi Arabia diabetes market industry by analysing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. SWOT analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the Saudi Arabia diabetes market industry. Furthermore, the value chain analysis of the Saudi Arabia diabetes market industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing, sales and distribution.
Saudi Arabia Diabetes Market Segment Insights:
The Saudi Arabia diabetes market has been analysed as followed:
By Region:
Competative Landscape:
The report has also analysed the competitive landscape of the Saudi Arabia diabetes market and provides the profiles of the major players.
Highlights of the Saudi Arabia Diabetes Market Report:
Report Customisation:
The Saudi Arabia diabetes market report can be customised as per your requirements. You can get in touch with our analyst, who will make sure that the report suits your research needs
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Diabetes Disease Overview
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications
6 Saudi Arabia Diabetes Epidemiology
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 Saudi Arabia Diabetes Market
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Forecast
7.5 SWOT Analysis
7.5.1 Overview
7.5.2 Strengths
7.5.3 Weaknesses
7.5.4 Opportunities
7.5.5 Threats
7.6 Value Chain Analysis
7.7 Porter’s Five Forces Analysis
7.7.1 Overview
7.7.2 Bargaining Power of Buyers
7.7.3 Bargaining Power of Suppliers
7.7.4 Degree of Competition
7.7.5 Threat of New Entrants
7.7.6 Threat of Substitutes
7.8 Market Breakup by Segment
7.8.1 Saudi Arabia Oral Antidiabetics Market
7.8.1.1 Historical Market Trends
7.8.1.2 Market Breakup by Class
7.8.1.3 Market Shares of Key Players
7.8.1.4 Market Forecast
7.8.2 Saudi Arabia Insulin Market
7.8.2.1 Historical Market Trends
7.8.2.2 Market Breakup by Class
7.8.2.3 Market Shares of Key Players
7.8.2.4 Market Forecast
8 Competitive Landscape
8.1 Competitive Structure
8.2 Profiles of Key Players
List of Figures
Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2021 & 2027
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: Saudi Arabia: Total Number of Diabetes Patients (in 000), 2016-2021
Figure 6: Saudi Arabia: Total Number of Diabetes Patients Forecast (in 000), 2022-2027
Figure 7: Saudi Arabia (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2016-2021
Figure 8: Saudi Arabia (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2022-2027
Figure 9: Saudi Arabia (Urban & Rural): Total Number of Diabetes Patients (in 000), 2016-2021
Figure 10: Saudi Arabia (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2022-2027
Figure 11: Saudi Arabia (Male & Female): Total Number of Diabetes Patients (in 000), 2016-2021
Figure 12: Saudi Arabia (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2022-2027
Figure 13: Saudi Arabia: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, - in 000), 2016-2021
Figure 14: Saudi Arabia: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, - in 000), 2022-2027
Figure 15: Saudi Arabia: Diabetes Drug Industry Overview
Figure 16: Saudi Arabia: Diabetes Drug Market: Sales Value (in Million US$), 2016-2021
Figure 17: Saudi Arabia: Diabetes Drug Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Saudi Arabia: Diabetes Drug Market: SWOT Analysis
Figure 19: Saudi Arabia: Diabetes Drug Market: Value Chain Analysis
Figure 20: Saudi Arabia: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: Saudi Arabia: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2016-2021
Figure 22: Saudi Arabia: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2022-2027
Figure 23: Saudi Arabia: Oral Antidiabetics Market: Sales Value (in Million US$), 2016-2021
Figure 24: Saudi Arabia: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2016 & 2021
Figure 25: Saudi Arabia: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: Saudi Arabia: Oral Antidiabetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Saudi Arabia: Insulin Market: Sales Value (in Million US$), 2016-2021
Figure 28: Saudi Arabia: Breakup of Insulin Market by Class (in %), 2016 & 2021
Figure 29: Saudi Arabia: Insulin Market: Sales Share of Key Players (in %)
Figure 30: Saudi Arabia: Insulin Market Forecast: Sales Value (in Million US$), 2022-2027
List of Tables
Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2021 & 2027
Table 3: Saudi Arabia: Total Prevalence & Number of Diabetes Patients, 2011, 2019 & 2025
Table 4: Saudi Arabia (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2011, 2019 & 2025
Table 5: Saudi Arabia (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2011, 2019 & 2025
Table 6: Saudi Arabia (Male & Female): Total Prevalence & Number of Diabetes Patients, 2011, 2019 & 2025
Table 7: Saudi Arabia: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79 - in 000), 2011, 2019 & 2025
Table 8: Saudi Arabia: Diabetes Drug Market: Competitive Structure
Personalize this research
Triangulate with your own data
Get data as per your format and definition
Gain a deeper dive on a specific application, geography, customer or competitor
Any level of personalization
US: +1-213-316-7435
Uk: +44-702-409-7740
sales@syndicatedanalytics.com
The GCC Weight Management Market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. The market is projected to register a CAGR of X% during 2023-2028, reaching US$ XX Billion by 2028.
Read More The GCC orthopedic braces and supports market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe GCC generic drug market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe GCC telemedicine market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe UAE mhealth market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe Saudi Arabia health insurance market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read More+1-213-316-7435
us.sales@syndicatedanalytics.com
+44-702-409-7740
uk.sales@syndicatedanalytics.com
© Copyright Syndicated Analytics 2023.